마일스톤 파마슈티컬스(Milestone Pharmaceuticals Inc.)
US ˙ NasdaqGS ˙ CA59935V1076

SecurityMIST / Milestone Pharmaceuticals Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership195,099 shares
Latest Disclosed Value $ 394,100
Group One Trading, L.p. ownership in MIST / Milestone Pharmaceuticals Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 195,099 shares of Milestone Pharmaceuticals Inc. (US:MIST) valued at $394,100 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 7,022 shares of Milestone Pharmaceuticals Inc.. This represents a change in shares of 2,678.40% during the quarter. The current value of the position is $239,972 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (MIST) in the form of stock options. The firm currently holds call options representing 165,400 of underlying shares valued at $334,108 USD and put options representing 374,500 of underlying shares valued at $756,490 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MIST / Milestone Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 195,099 188,077 2,678.40 394 2,714.29 0.0007
2025-11-12 2025-09-30 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 7,022 -24,594 -77.79 14 -77.05 0.0000
2025-08-14 2025-06-30 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 31,616 -106,744 -77.15 61 -44.55 0.0001
2025-05-14 2025-03-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 138,360 85,723 162.86 111 -11.29 0.0003
2025-05-14 2024-12-31 13F/A-1 MILESTONE PHARMACEUTICALS IN COM 59935V107 52,637 52,637 124 0.0003
2025-02-14 2024-12-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 52,637 52,637 124 0.0003
2024-05-10 2024-03-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 0 -20,762 -100.00 0 -100.00
2024-02-14 2023-12-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 20,762 20,762 35 0.0001
2023-08-09 2023-06-30 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 0 -242 -100.00 0 0.0000
2023-05-12 2023-03-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 242 -30,385 -99.21 1 -100.00 0.0000
2023-02-09 2022-12-31 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 30,627 26,379 620.97 121 210.26 0.0003
2022-11-09 2022-09-30 13F MILESTONE PHARMACEUTICALS IN COM 59935V107 4,248 4,248 39 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F MILESTONE PHARMACEUTICALS IN COM Call 165,400 470.34 334 475.86 n/a n/a n/a
2025-11-12 2025-09-30 13F MILESTONE PHARMACEUTICALS IN COM Call 29,000 -70.10 58 -69.15 n/a n/a n/a
2025-08-14 2025-06-30 13F MILESTONE PHARMACEUTICALS IN COM Call 97,000 32,233.33 188 n/a n/a n/a
2025-05-14 2025-03-31 13F MILESTONE PHARMACEUTICALS IN COM Call 300 0 n/a n/a n/a
2024-05-10 2024-03-31 13F MILESTONE PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F MILESTONE PHARMACEUTICALS IN COM Call 7,700 -95.97 13 -97.98 n/a n/a n/a
2023-11-09 2023-09-30 13F MILESTONE PHARMACEUTICALS IN COM Call 191,300 593 n/a n/a n/a
2023-08-09 2023-06-30 13F MILESTONE PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-12 2023-03-31 13F MILESTONE PHARMACEUTICALS IN COM Call 193,400 114.17 762 113.17 n/a n/a n/a
2023-02-09 2022-12-31 13F MILESTONE PHARMACEUTICALS IN COM Call 90,300 568.89 358 187.90 n/a n/a n/a
2022-11-09 2022-09-30 13F MILESTONE PHARMACEUTICALS IN COM Call 13,500 124 n/a n/a n/a
2022-08-11 2022-06-30 13F MILESTONE PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F MILESTONE PHARMACEUTICALS IN COM Call 46,300 46,200.00 297 29,600.00 n/a n/a n/a
2022-02-11 2021-12-31 13F MILESTONE PHARMACEUTICALS IN COM Call 100 -99.62 1 -99.34 n/a n/a n/a
2021-11-12 2021-09-30 13F MILESTONE PHARMACEUTICALS IN COM Call 26,600 303.03 152 322.22 n/a n/a n/a
2021-08-10 2021-06-30 13F MILESTONE PHARMACEUTICALS IN COM Call 6,600 -79.11 36 -80.33 n/a n/a n/a
2021-05-12 2021-03-31 13F MILESTONE PHARMACEUTICALS IN COM Call 31,600 183 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F MILESTONE PHARMACEUTICALS IN COM Put 374,500 2,396.67 756 2,420.00 n/a n/a n/a
2025-11-12 2025-09-30 13F MILESTONE PHARMACEUTICALS IN COM Put 15,000 2,900.00 30 n/a n/a n/a
2025-08-14 2025-06-30 13F MILESTONE PHARMACEUTICALS IN COM Put 500 -95.15 1 -100.00 n/a n/a n/a
2025-05-14 2025-03-31 13F MILESTONE PHARMACEUTICALS IN COM Put 10,300 -85.09 8 -95.09 n/a n/a n/a
2025-05-14 2024-12-31 13F/A MILESTONE PHARMACEUTICALS IN COM Put 69,100 163 n/a n/a n/a
2025-02-14 2024-12-31 13F MILESTONE PHARMACEUTICALS IN COM Put 69,100 163 n/a n/a n/a
2024-11-14 2024-09-30 13F MILESTONE PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F MILESTONE PHARMACEUTICALS IN COM Put 20,000 0.00 27 -25.71 n/a n/a n/a
2024-05-10 2024-03-31 13F MILESTONE PHARMACEUTICALS IN COM Put 20,000 -77.75 36 -76.67 n/a n/a n/a
2024-02-14 2023-12-31 13F MILESTONE PHARMACEUTICALS IN COM Put 89,900 0.00 150 -46.04 n/a n/a n/a
2023-11-09 2023-09-30 13F MILESTONE PHARMACEUTICALS IN COM Put 89,900 279 n/a n/a n/a
2023-08-09 2023-06-30 13F MILESTONE PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-12 2023-03-31 13F MILESTONE PHARMACEUTICALS IN COM Put 42,800 -61.09 169 -61.38 n/a n/a n/a
2023-02-09 2022-12-31 13F MILESTONE PHARMACEUTICALS IN COM Put 110,000 384.58 436 108.13 n/a n/a n/a
2022-11-09 2022-09-30 13F MILESTONE PHARMACEUTICALS IN COM Put 22,700 209 n/a n/a n/a
2021-11-12 2021-09-30 13F MILESTONE PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F MILESTONE PHARMACEUTICALS IN COM Put 4,400 238.46 24 200.00 n/a n/a n/a
2021-05-12 2021-03-31 13F MILESTONE PHARMACEUTICALS IN COM Put 1,300 8 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.